News
- Author:
- Richard Mark Kirkner
Publish date: December 21, 2023
Wearables, in the form of smartwatches and smartphone connections, are finding their place in monitoring pulmonary disorders, but more innovative r...
News
- Author:
- Richard Mark Kirkner
Publish date: December 18, 2023
A total of 81% of patients who received the iDose TR did not require supplemental drops to reduce IOP after 12 months compared with 95% of those wh...
News
- Author:
- Richard Mark Kirkner
Publish date: December 14, 2023
The extent of this thinning predicts whether kidney function will decline going forward over a period of 2 or 3 years.
News
- Author:
- Richard Mark Kirkner
Publish date: November 28, 2023
Recaticimab, an investigational PCSK9 inhibitor, has shown durable lowering of low-density lipoprotein cholesterol with injection frequencies of 1-...
News
- Author:
- Richard Mark Kirkner
Publish date: November 22, 2023
A pilot study shows that an intervention that gives physicians and patients information on out-of-pocket costs for heart failure drugs can help ens...
News
- Author:
- Richard Mark Kirkner
Publish date: November 20, 2023
The first in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial hyper...
News
- Author:
- Richard Mark Kirkner
Publish date: November 16, 2023
An artificial intelligence electrocardiography app cut catheterization lab activation times by 9 minutes in ST-elevation myocardial infarction pati...
News
- Author:
- Richard Mark Kirkner
Publish date: November 15, 2023
The findings do not obviate the need for providers to have a conversation about the potential risks to vision posed by the drug.
News
- Author:
- Richard Mark Kirkner
Publish date: November 14, 2023
A clinical trial in Canada has found that small-volume blood collection tubes equal standard-volume tubes for specimen capture while reducing blood...
News
- Author:
- Richard Mark Kirkner
Publish date: November 13, 2023
“We’ve always thought that somehow aspirin prevents stroke and prevents clotting and that it’s anti-inflammatory, and what we found in ARIES was th...
News
- Author:
- Richard Mark Kirkner
Publish date: November 13, 2023
“From my perspective, DAPA-MI does not suggest a new mandate to expand SGLT2 inhibition to an isolated MI population without other SGLT2 inhibitor ...
News
- Author:
- Richard Mark Kirkner
Publish date: October 10, 2023
Almost 90 clinical trials are evaluating drugs to that target unmet needs for treating idiopathic pulmonary fibrosis.
News
- Author:
- Richard Mark Kirkner
Publish date: September 29, 2023
“Clinicians need better awareness that the need to change residence is an important marker of changing health status and may portend end-of-life ev...
News
- Author:
- Richard Mark Kirkner
Publish date: August 18, 2023
Fewer than 10% of early Alzheimer’s patients in a real-world cohort would qualify for trials of anti–amyloid-beta monoclonal antibodies, a study fo...
News
- Author:
- Richard Mark Kirkner
Publish date: August 11, 2023
Emerging artificial intelligence tools in pulmonology are crunching electronic records and physiological signals to improve predictive models.
